Viewing Study NCT00227032


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-04-04 @ 3:42 AM
Study NCT ID: NCT00227032
Status: TERMINATED
Last Update Posted: 2012-03-06
First Post: 2005-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult giant cell glioblastoma View
None adult gliosarcoma View
None adult glioblastoma View
None recurrent adult brain tumor View